Straits Times Index
3,296.44 -17.61 (-0.53%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,228.96 -407.26 (-2.07%) FTSE 100
8,424.20 +3.94 (+0.05%) Bitcoin USD
71,123.79 +4,107.37 (+6.13%) CMC Crypto 200
1,527.89 +39.34 (+2.64%)
Insmed Incorporated (INSM)
After hours:
| Previous close | 24.77 |
| Open | 24.81 |
| Bid | 25.52 x 600 |
| Ask | 25.55 x 600 |
| Day's range | 24.60 - 25.62 |
| 52-week range | 18.31 - 32.00 |
| Volume | |
| Avg. volume | 1,769,220 |
| Market cap | 3.795B |
| Beta (5Y monthly) | 0.93 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that late-breaking data from the ARISE study of ARIKAYCE® (amikacin liposome inhalation suspension) were presented at the American Thoracic Society (ATS) 2024 International Conference in San Diego. Data from ARISE evaluating patients with newly diagnosed or recurrent nontuberculous mycobacterial (NTM) lung infection caused by Mycob
- PR Newswire
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the first quarter ended March 31, 2024 and provided a business update.
- PR Newswire
Insmed To Present at the BofA Securities Health Care Conference 2024
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at the BofA Securities Health Care Conference 2024 in Las Vegas, NV, on Tuesday, May 14, 2024 at 2:20 p.m. PT (5:20 p.m. ET).
